Close Menu

The Wall Street Journal reports on innovative approaches to getting people to enroll in clinical trials, including one that it describes as "a sort of medical matchmaker that is gaining wider usage: EmergingMed, a for-profit service that connects patients to cutting-edge clinical trials." Let's hope one of these programs works. While they may not realize it, consumers are an essential part of the biomedical enterprise and new treatments can't emerge without them.

 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The UK has given emergency authorization for Pfizer and BioNTech's SARS-CoV-2 vaccine, the Associated Press reports.

A US advisory committee says healthcare workers and nursing home residents should be prioritized to receive a SARS-CoV-2 vaccine, according to the Financial Times.

The Wall Street Journal reports North Korean hackers have targeted half a dozen companies developing SARS-CoV-2 vaccines.

In Cell this week: long-term SARS-CoV-2 shedding, examination of the effects of a coronavirus spike protein mutation, and more.